NCT05294900 2022-03-25
NEOS
Yonsei University
Phase 2 Unknown
Clinical Trials
10 trialsNCT04982549 2021-08-06
A Study to Evaluate the Safety of Concurrent Durvalumab With CRT Followed by Durvalumab for Chinese Unresectable Stage III NSCLC
Shandong Cancer Hospital and Institute
Phase 2 Unknown
NCT04337632 2021-04-08
Evaluation of the Sensitivity to Different Chemotherapy Regimens in Platinum-Partial Sensitive Recurrent Ovarian Cancer
Hunan Cancer Hospital
Phase 3 Unknown
NCT03940001 2019-09-09
A Study of Sintilimab Plus Chemoradiation Before Surgery for Esophageal Cancer
Zhejiang Cancer Hospital
Phase EARLY_PHASE1 Unknown
NCT02924909 2018-03-20
QUIMERA
Instituto Nacional de Cancer, Brazil
Phase 2 Unknown
NCT02207361 2015-12-22
Paclitaxel in Combination With Carboplatin Versus Paclitaxel Plus Epirubicin in Metastatic Breast Cancer
Tianjin Medical University Cancer Institute and Hospital
Phase 4 Unknown
NCT01872403 2013-06-07
Neoadjuvant Chemotherapy of Nanoparticle Albumin-bound Paclitaxel/Carboplatin vs. Paclitaxel /Carboplatin in Stage â…¡ B and IIIA Squamous Cell Carcinoma of the Lung
The First Affiliated Hospital of Guangzhou Medical University
Phase 2 Unknown
NCT01527864 2012-02-07
Paclitaxel-Carboplatin Alone or With M2ES for Non-Small-Cell Lung Cancer
Protgen Ltd
Phase 2 Unknown
NCT01158144 2010-07-08
Concurrent Endostar, Paclitaxel/Carboplatin and Radiotherapy for Locally Advanced Non-small Cell Lung (RT0902)
Zhejiang Cancer Hospital
Phase 2 Unknown
NCT00894569 2009-05-14
PACET-CUP
Heidelberg University
Phase 2 Unknown